Abstract
Introduction
Breast cancer is the second most common malignancy in Korean women, and the incidence has increased recently [1] . In patients with breast cancer, 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET/CT) is very useful in the initial staging of locally advanced and inflammatory cancer, prediction of recurrence and restaging of cancer [2, 3] .
Breast cancer exhibits various recurrence patterns, and about one-third of patients have recurrence even in the early stage [4, 5] . The first sites of breast cancer recurrence include the locoregional site, contralateral breast, lymph nodes, bone, viscera, bone marrow, lung, liver and central nervous system [5] . Well-known risk factors of breast cancer recurrence include tumor size, lymph node status, histologic subtype, surgical margin status and lymphovascular invasion. In case of neoadjuvant treatment before breast-conserving surgery, the estrogen receptor (ER) status and multifocality of the residual tumor are included [6] . Therefore, meticulous surveillance after surgery is needed.
Horner's syndrome is caused by interruption of the sympathetic pathway to the eye and face, causing ipsilateral miosis, partial ptosis, apparent enophthalmos and anhidrosis [7] . It can be acquired as a result of malignancy such as Pancoast tumor, even if it is rare, but also can be inborn or due to trauma. Here, we report the case of a patient with unusual Horner's syndrome caused by impingement of a metastatic lymph node to the cervical sympathetic trunk detected by FDG PET/CT.
Case Report
A 38-year-old female was diagnosed with right breast cancer and underwent modified radical mastectomy (MRM) after neoadjuvant chemotherapy. At first, her clinical stage was T2N3 because of metastatic lymphadenopathy in the right axillary area from level I to III (Fig. 1) . The final pathologic stage was ypT2N2. The pathological results were invasive ductal carcinoma with ER-positive, progesterone receptor (PR)-positive and human epidermal growth factor receptor 2 (HER2) negative. Before surgery, she underwent neoadjuvant chemotherapy but progressed.
After surgery, she underwent extended radiotherapy in the chest wall, covering the right axillary area up to level III, and underwent hormone therapy.
During follow-up after surgery, 2 years after MRM, she complained of a droopy eyelid on the right side, which was felt 2 months before visiting a regular outpatient clinic (Fig. 2) . She was referred to the ophthalmic clinic for the specific examination. After examination, the ophthalmologist diagnosed her symptom as ptosis of the right eye, which could be the result of the recurrence of breast cancer considering her previous history of advanced breast cancer. Unusual Horner's syndrome due to recurrence was one of the suspected diagnoses.
In suspicion of recurrence, the patient underwent FDG PET/ CT to find the recurring lesion and the anatomical focus along the cervical sympathetic trunk in case of Horner's syndrome. For the exclusion of brain disease or ocular disease that can cause ptosis, brain magnetic resonance imaging (MRI) was performed too. FDG PET/CT revealed a hypermetabolic lesion in the right cervicothoracic junction area with no other abnormal finding in the whole body (Fig. 3) . The maximum standardized uptake value (SUVmax) of the lesion was 6.6. Brain MRI revealed no abnormal finding causing ptosis. Considering the location of the lesion, Horner's syndrome was the most appropriate cause of ptosis in our patient, and we could classify it as the preganglionic type of Horner's syndrome.
Pathologic confirmation was needed for further management, and an ultrasonography (US)-guided biopsy was carried out. In the US, an about 2.3-cm ill-defined hypoechoic lesion was found, and a subsequent needle biopsy was performed (Fig. 4) . This lesion was pathologically confirmed as metastatic ductal carcinoma with ER/PR/HER-2 all negative and was suspected to impinge on the cervical sympathetic trunk and cause Horner's syndrome on the ipsilateral side. The patient was enrolled in the clinical trial and underwent chemotherapy, combined paclitaxel and cobimetinib. The ptosis improved after chemotherapy.
Discussion
Horner's syndrome is caused by interruption of the cervical sympathetic trunk, resulting in ipsilateral miosis, partial ptosis, apparent enophthalmos and anhidrosis [7] . The sympathetic nerve pathway can be interrupted along its course, and acquired Horner's syndrome can be classified into three types by the location: central, preganglionic and postganglionic Horner's syndrome [8] . Among them, preganglionic Horner's syndrome is most often caused by trauma or a tumor [9] . In case of a tumor, lung cancer, especially Pancoast tumor and mediastinal tumors can impinge on cervical sympathetic neurons.
Breast cancer recurrence after curative surgery occurs with various patterns, and in case of patients with neoadjuvant chemotherapy, the response to therapy has predictive value in the clinical outcome [5, 10] . Our patient had progressive disease after neoadjuvant chemotherapy, so meticulous follow-up was needed because of the high risk of recurrence. Approximately 2 years later, the patient had ptosis in the right eye. There are various disease entities that could cause ptosis, but considering her previous history of advanced breast cancer, Horner's syndrome due to a metastatic lesion originating from breast cancer was considered. There are several previous reports about Horner's syndrome due to breast cancer metastasis. Kovacic Fig. 2 Ptosis in the right eye. A droopy right eyelid is evident, and Horner's syndrome was suspected. Informed consent was obtained from the patient for the use of this image [11] . Malignant pleural effusion was the cause of the sympathetic lesion. Tjalma also reported a case of Horner's syndrome due to breast cancer metastasis in the upper mediastinal lymph nodes [12] . Horner's syndrome caused by metastatic breast cancer is very rare, but it occurs, and it is one of the neurologic complications of breast cancer [13] . Therefore, if a patient with a previous history of breast cancer has ptosis, Horner's syndrome due to recurrence should be considered.
FDG PET/CT for the evaluation of recurrent malignancy exhibited excellent diagnostic performance in advanced breast cancer patients [14] . In our case, there was a hypermetabolic lesion in the right cervicothoracic junction area, which exhibited prominent FDG uptake. Initially, the patient had metastatic lymph nodes from axilla level I to level III. She got adjuvant radiotherapy after surgery, but the radiation field did not cover the right cervicothoracic junction area. The lesion in the cervicothoracic junction could be a recurrent lesion, considering both the patient's previous history and the FDG avidity of the lesion. The lesion was finally pathologically confirmed as metastatic ductal carcinoma. FDG PET/CT was able to detect the rare case of Horner's syndrome due to breast cancer recurrence and could classify its type by the location of the lesion.
In conclusion, we report the first case in which FDG PET/ CT revealed breast cancer recurrence presenting as Horner's syndrome. When the patient has ptosis or other symptoms suggesting Horner's syndrome with a previous history of breast cancer, metastasis should be considered. FDG PET/ CT could be helpful to localize the recurrent lesion. Meticulous concern about the anatomical site and relation to the patient's symptoms should be given, and FDG PET/CT could be useful for the evaluation of recurrence.
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b a c Fig. 3 FDG PET/CT image when Horner's syndrome was suspected. In the MIP image, a hypermetabolic lesion (SUVmax 6.6) was found in the right cervicothoracic junction area (a) and transaxial PET (b) and fusion transaxial PET/CT image (c) Fig. 4 US finding of the right cervicothoracic junction area. An illdefined low echoic infiltrative lesion was found, and needle biopsy was done. The lesion was confirmed to be metastatic ductal carcinoma
